Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

New Blood Thinner Tops Plavix in Trials

But prasugrel also adds risk of bleeding to death

By Kevin Spak,  Newser Staff

Posted Nov 5, 2007 9:00 AM CST

(Newser) – An experimental new blood-thinner looks like real competition for top-selling anti-clotting drug Plavix, after proving more effective at preventing heart attacks, strokes, and heart-related death in a recent trial, the AP reports. But “there is a price to pay” for increased effectiveness, wrote one doctor—the new drug caused an extra bleeding death for each heart-related one it prevented.

Despite that risk, many doctors want the FDA to approve prasugrel, because Plavix is expensive and doesn’t work for everyone. Doctors, they argue, won’t prescribe the drug for high-risk patients, like the elderly or previous stroke victims. But the drug’s makers canceled two tests on those groups, “because of a risk of a safety problem,” they said.

Blood thinner medication Plavix is shown July 28, 2006 in a New York file photo. (AP Photo/Mark Lennihan, File)
Blood thinner medication Plavix is shown July 28, 2006 in a New York file photo. (AP Photo/Mark Lennihan, File)   (Associated Press)
Dr. Steven Nissen poses in his lab at the Cleveland Clinic beside screens with images of coronary arteries as seen by intravascular ultrasound in Cleveland, Ohio, Jan. 16, 2004. The experimental drug, prasugrel, a new blood thinner proved better than Plavix, one of the world's top-selling drugs, at preventing heart...
Dr. Steven Nissen poses in his lab at the Cleveland Clinic beside screens with images of coronary arteries as seen by intravascular ultrasound in Cleveland, Ohio, Jan. 16, 2004. The experimental drug,...   (Associated Press)
« Prev« Prev | Next »Next » Slideshow
To report an error on this story, notify our editors.
A snapshot of the day's best news stories.
 
COMMENTS
Be the first to comment on this story.

More Newser Stories

Controversy Rages Over Diabetes Drug's Heart Risks

Stents Show No Lasting Benefit In Heart Study

Heart Patients Told Sex Is Safe—but Not Affairs

FDA Takes Over 3 Tylenol Plants

Simple Technique Could Bypass Cardiac Arrest


NEWS FROM OUR PARTNERS
Other Sites We Like:   24/7 Wall St.   |   Betty Confidential   |   BuzzFeed   |   Cracked   |   Fark   |   Timelines   |   The Frisky   |   Geek Sugar   |   NewsOne